Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
Abstract Background Aptamer has been called “chemical antibody” which displays the specific affinity to target molecules compared to that of antibodies and possesses several therapeutic advantages over antibodies in terms of size, accessibility to synthesis, and modification. Based on the attractive...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Association for the Advancement of Science (AAAS)
2021-11-01
|
| סדרה: | Biomaterials Research |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s40824-021-00244-4 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|